1
|
Tsuchiya T, Umeda M, Nishiyama H, Yoshimura I, Ajimi S, Asakura M, Baba H, Dewa Y, Ebe Y, Fushiwaki Y, Hamada S, Hamamura T, Hayashi M, Iwase Y, Kajiwara Y, Kasahara Y, Kawabata M, Kitada E, Kubo K, Mashiko K, Miura D, Mizuhashi F, Mizuno F, Nakajima M, Nakamura Y, Nobe N, Oishi H, Ota E, Sakai A, Sato M, Shimada S, Sugiyama T, Takahashi C, Takeda Y, Tanaka N, Toyoizumi C, Tsutsui T, Wakuri S, Yajima S, Yajima N. An Interlaboratory Validation Study of the Improved Transformation Assay Employing Balb/c 3T3 Cells: Results of a Collaborative Study on the Two-stage Cell Transformation Assay by the Non-genotoxic Carcinogen Study Group. Altern Lab Anim 2019; 27:685-702. [DOI: 10.1177/026119299902700409] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The Non-genotoxic Carcinogen Study Group of the Environmental Mutagen Society of Japan organised the first step of an interlaboratory validation study on an improved cell transformation assay employing Balb/c 3T3 A31-1-1 cells. Nineteen laboratories participated in this study. The modified transformation assay was evaluated for its responsiveness, its inter-laboratory reproducibility and its transferability. In this study, a mixture of Dulbecco's modified Eagle's medium and nutrient mixture F12, supplemented with insulin–transferrin– ethanolamine–sodium selenite and 2% fetal bovine serum (FBS) was used during the period of expression of transformed foci, intead of the usual minimum essential medium with 10% FBS. 20-Methylcholanthrene (MCA) and 12 -O-tetradecanoylphorbol-13-acetate (TPA) were selected as a prototype initiator and a tumour promoter, respectively. Two series of experiments were conducted. In the first series, the transformation activity of MCA was examined at various concentrations. In the absence of the promoting treatment with TPA, exposure to MCA only weakly induced transformed foci. In the presence of 0.1μg/ml TPA, all laboratories observed significant dose-dependent increases in the number of transformed foci with increasing MCA concentrations. In the second series of experiments, various concentrations of TPA were tested. In the absence of initiating treatment with MCA, exposure to TPA weakly induced transformed foci in about half of the laboratories. In the presence of 0.2μg/ml MCA, all the laboratories observed significant dose-dependent increases in the number of transformed foci with increasing TPA concentrations. The results from this study support the usefulness of this modified two-stage transformation assay with Balb/c 3T3 cells.
Collapse
Affiliation(s)
- Toshiyuki Tsuchiya
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Makoto Umeda
- Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano, Kanagawa 257-0025, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Hiroshi Nishiyama
- Faculty of Engineering, Science University of Tokyo, Kagurazaka, Tokyo 162-8601, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Isao Yoshimura
- Faculty of Engineering, Science University of Tokyo, Kagurazaka, Tokyo 162-8601, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Shozo Ajimi
- Hita Research Laboratories Chemical Biotesting Center, Chemicals Inspection and Testing Institute, 822, 3-chome, Ishii-machi, Hita, Oita 877-0061, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Masumi Asakura
- Japan Bioassay Research Center, 2445 Hirasawa, Hadano, Kanagawa 257-0015, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Hiroshi Baba
- Toxicology Laboratory, Yokohama Research Center, Mitsubishi Chemical Corporation, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-8502, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Yasuaki Dewa
- Research Center, Kyorin Pharmaceutical Co. Ltd, 1848 Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Youji Ebe
- Life Sciences Laboratory, Performance Materials R&D Center, Mitsui Chemicals Inc., 1144 Togo, Mobara-shi, Chiba 297-0017, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Yuichi Fushiwaki
- Water Section, Kanagawa Environmental Research Center, 842 Nakaharashimojuku, Hiratsuka, Kanagawa 254-0072, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Shuichi Hamada
- Central Research Laboratories, SSP Co. Ltd, 1143 Nanpeidai, Narita, Chiba 286-8511, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Tetsuo Hamamura
- Water Section, Kanagawa Environmental Research Center, 842 Nakaharashimojuku, Hiratsuka, Kanagawa 254-0072, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Makoto Hayashi
- National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Yumiko Iwase
- Toxicology Laboratory, Yokohama Research Center, Mitsubishi Chemical Corporation, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-8502, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Yoshitsugu Kajiwara
- Hita Research Laboratories Chemical Biotesting Center, Chemicals Inspection and Testing Institute, 822, 3-chome, Ishii-machi, Hita, Oita 877-0061, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Yasushi Kasahara
- Research Center, Kyorin Pharmaceutical Co. Ltd, 1848 Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Masayoshi Kawabata
- Snow Brand Milk Products Co. Ltd, 519 Shimoishibashi, Ishibashi-machi, Shimotsuga-gun, Tochigi 329-0512, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Emiko Kitada
- Pharmaceutical Development Laboratory, Kirin Brewery Co. Ltd, 2-2 Souja-machi 1-chome, Maebashi-shi, Gunma 371-0853, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Kinya Kubo
- Pharmaceutical Development Laboratory, Kirin Brewery Co. Ltd, 2-2 Souja-machi 1-chome, Maebashi-shi, Gunma 371-0853, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Kaori Mashiko
- Research Center, Kyorin Pharmaceutical Co. Ltd, 1848 Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Daisaku Miura
- Experimental Toxicology Department, Biosafety Research Center, Foods, Drugs and Pesticides, 582-2 Shioshinden, Fukude-cho, Iwatagun, Shizuoka 437-1213, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Fukutaro Mizuhashi
- Kumiai Chemical Industry Co. Ltd, 3360 Kamo, Kikugawacho, Ogasa-gun, Shizuoka 439-0031, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Fumio Mizuno
- Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd, 14 Sunayama, Hasaki-machi, Kashima-gun, Ibaraki 314-0255, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Madoka Nakajima
- Experimental Toxicology Department, Biosafety Research Center, Foods, Drugs and Pesticides, 582-2 Shioshinden, Fukude-cho, Iwatagun, Shizuoka 437-1213, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Yoshiyuki Nakamura
- School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka-si, Shizuoka 422-8002, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Naoko Nobe
- Central Research Laboratories, SSP Co. Ltd, 1143 Nanpeidai, Narita, Chiba 286-8511, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Hidetoshi Oishi
- Developmental Research Laboratories, Dainippon Pharmaceutical Co. Ltd, Enoki 33-94, Suita, Osaka 564-0053, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Erina Ota
- Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd, 14 Sunayama, Hasaki-machi, Kashima-gun, Ibaraki 314-0255, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Ayako Sakai
- National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Miho Sato
- School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka-si, Shizuoka 422-8002, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Sawako Shimada
- Experimental Toxicology Department, Biosafety Research Center, Foods, Drugs and Pesticides, 582-2 Shioshinden, Fukude-cho, Iwatagun, Shizuoka 437-1213, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Toshie Sugiyama
- Japan Bioassay Research Center, 2445 Hirasawa, Hadano, Kanagawa 257-0015, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Chitose Takahashi
- Snow Brand Milk Products Co. Ltd, 519 Shimoishibashi, Ishibashi-machi, Shimotsuga-gun, Tochigi 329-0512, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Yuko Takeda
- Toxicology Laboratory, Yokohama Research Center, Mitsubishi Chemical Corporation, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-8502, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Noriho Tanaka
- Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano, Kanagawa 257-0025, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Chikako Toyoizumi
- Chemical Products Quality Assurance Center, Canon Inc., 30-2 Shimomaruko 3-chome, Ohta-ku, Tokyo 146-8501, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Takeki Tsutsui
- School of Dentistry at Tokyo, The Nippon Dental University, 1-9-20 Fujimi, Chiyoda-ku, Tokyo 102-8159, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Shinobu Wakuri
- Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano, Kanagawa 257-0025, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Satoshi Yajima
- Central Research Laboratory, Takasago International Corporation, 4-11, 1-chome Nishiyawata, Hiratsuka, Kanagawa 254-0073, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| | - Nobuhiro Yajima
- Snow Brand Milk Products Co. Ltd, 519 Shimoishibashi, Ishibashi-machi, Shimotsuga-gun, Tochigi 329-0512, Japan
- Safety Evaluation Center, Central Research Laboratory, Showa Denko K.K., 1-1-1 Ohnodai, Midori-ku, Chiba 267-0056, Japan
| |
Collapse
|
2
|
Tsuchiya T, Umeda M, Tanaka N, Sakai A, Nishiyama H, Yoshimura I, Ajimi S, Asada S, Asakura M, Baba H, Dewa Y, Ebe Y, Fushiwaki Y, Hagiwara Y, Hamada S, Hamamura T, Iwase Y, Kajiwara Y, Kasahara Y, Kato Y, Kawabata M, Kitada E, Kaneko K, Kizaki Y, Kubo K, Miura D, Mashiko K, Mizuhashi F, Muramatsu D, Nakajima M, Nakamura T, Oishi H, Sasaki T, Shimada S, Takahashi C, Takeda Y, Wakuri S, Yajima N, Yajima S, Yatsushiro T. Application of the Improved BALB/c 3T3 Cell Transformation Assay to the Examination of the Initiating and Promoting Activities of Chemicals: The Second Inter-laboratory Collaborative Study by the Non-genotoxic Carcinogen Study Group of Japan. Altern Lab Anim 2010; 38:11-27. [DOI: 10.1177/026119291003800111] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The Non-genotoxic Carcinogen Study Group in the Environmental Mutagen Society of Japan organised the second step of the inter-laboratory collaborative study on one-stage and two-stage cell transformation assays employing BALB/c 3T3 cells, with the objective of confirming whether the respective laboratories could independently produce results relevant to initiation or promotion. The method was modified to use a medium consisting of DMEM/F12 supplemented with 2% fetal bovine serum and a mixture of insulin, transferrin, ethanolamine and sodium selenite, at the stationary phase of cell growth. Seventeen laboratories collaborated in this study, and each chemical was tested by three to five laboratories. Comparison between the one-stage and two-stage assays revealed that the latter method would be beneficial in the screening of chemicals. In the test for initiating activity with the two-stage assay (post-treated with 0.1μg/ml 12- O-tetradecanoylphorbol-13-acetate), the relevant test laboratories all obtained positive results for benzo[ a]pyrene and methylmethane sulphonate, and negative results for phenanthrene. Of those laboratories assigned phenacetin for the initiation phase, two returned positive results and two returned negative results, where the latter laboratories tested up to one dose lower than the maximum dose used by the former laboratories. In the exploration of promoting activity with the two-stage assay (pretreated with 0.2μg/ml 3-methylcholanthrene), the relevant test laboratories obtained positive results for mezerein, sodium orthovanadate and TGF-β1, and negative results for anthralin, phenacetin and phorbol. Two results returned for phorbol 12,13-didecanoate were positive, but one result was negative — again, the maximum dose to achieve the latter result was lower than that which produced the former results. These results suggest that this modified assay method is relevant, reproducible and transferable, provided that dosing issues, such as the determination of the maximum dose, are adequately considered. The application of this two-stage assay for screening the initiating and promoting potential of chemicals is recommended for consideration by other research groups and regulatory authorities.
Collapse
Affiliation(s)
| | - Makoto Umeda
- Hatano Research Institute, Food & Drug Safety Centre, Hadano, Japan
| | - Noriho Tanaka
- Hatano Research Institute, Food & Drug Safety Centre, Hadano, Japan
| | - Ayako Sakai
- Hatano Research Institute, Food & Drug Safety Centre, Hadano, Japan
| | - Hiroshi Nishiyama
- Tokyo University of Science, Tokyo, Japan
- Takeda Pharmaceutical Co. Ltd, Osaka, Japan
| | | | - Syozo Ajimi
- Chemicals Evaluation & Research Institute, Hita, Japan
| | - Shin Asada
- Hatano Research Institute, Food & Drug Safety Centre, Hadano, Japan
| | | | | | - Yasuaki Dewa
- Kyorin Pharmaceutical Co. Ltd, Shimotsuga, Japan
| | - Youji Ebe
- Mitsui Chemicals Inc., Mobara, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - Daisaku Miura
- Biosafety Research Centre — Foods, Drugs and Pesticides, Iwata, Japan
| | | | | | - Dai Muramatsu
- Hatano Research Institute, Food & Drug Safety Centre, Hadano, Japan
| | - Madoka Nakajima
- Biosafety Research Centre — Foods, Drugs and Pesticides, Iwata, Japan
| | | | | | | | - Sawako Shimada
- Biosafety Research Centre — Foods, Drugs and Pesticides, Iwata, Japan
| | | | - Yuko Takeda
- Mitsubishi Pharma Corporation, Kisarazu, Japan
| | - Sinobu Wakuri
- Hatano Research Institute, Food & Drug Safety Centre, Hadano, Japan
| | | | | | | |
Collapse
|